Board member Saiyed Atiq Raza sold 90,000 shares of Arteris, Inc. as part of a pre-arranged trading plan. The sale follows a period of significant stock appreciation fueled by demand for AI-related semiconductor IP.
- Sale of 90,000 shares totaling $1.99 million
- Executed via Rule 10b5-1 pre-planned trading schedule
- Stock price surged over 300% in one year
- 2025 revenue grew 22% to $70.6 million
- Company remains unprofitable with a $34.7 million net loss
- Current valuation reflects a price-to-sales ratio of 16
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.